Literature DB >> 9660226

Reduced glial cell line-derived neurotrophic factor level in aganglionic bowel in Hirschsprung's disease.

K Ohshiro1, P Puri.   

Abstract

BACKGROUND/
PURPOSE: Glial cell line-derived neurotrophic factor (GDNF) is suggested to be essential for the development of the enteric nervous system. The aim of this study was to investigate GDNF protein expression in human aganglionic (AG) bowel in Hirschsprung's disease (HD) using immunofluorescence and enzyme-linked immunosorbent assay (ELISA) analysis, to further understand the pathophysiology of HD.
METHODS: Colonic specimens were obtained from eight patients with HD (aged 7 days to 14 months) at the time of definite pull-through surgery, including both normoganglionic (NG) and aganglionic (AG) segments. Immunofluorescence was performed using anti-GDNF polyclonal antibody and FITC-conjugated secondary antibody on the formalin-fixed and paraffin-embedded specimens. For ELISA analysis, specimens were homogenized by adding 10 volumes of 10-mmol/L phosphate-buffered saline containing proteinase inhibitors. Centrifuged supernatant was used for the quantitative analysis using sandwich-type ELISA for human GDNF.
RESULTS: There was strong GDNF immunoreactivity in the mucosal epithelium, submucosal and myenteric plexuses, and hypertrophic nerve trunks. In the mucosa in AG bowel, the number of GDNF immunoreactive epithelial cells was significantly reduced compared with NG bowel (mean +/- SD, AG/NG = 227.2 +/- 73.1/310.8 +/- 80.5 GDNF immunoreactive cells per 100 crypts, P < .05). Using ELISA, the level of GDNF in full-thickness bowel was reduced significantly in AG bowel compared with NG bowel (mean +/- SD, AG/NG = 860.2 +/- 309.8/1777.5 +/- 271.4 pg/g wet tissue, P < .001).
CONCLUSION: Because GDNF is essential for the development of the enteric nervous system, our findings of reduced level of GDNF in AG bowel as well as reduced number of GDNF immunoreactive cells in the mucosa of AG bowel suggest that GDNF may play an important role in the pathogenesis of HD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660226     DOI: 10.1016/s0022-3468(98)90671-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

Review 1.  Enteric nervous system and developmental abnormalities in childhood.

Authors:  Thambipillai Sri Paran; Udo Rolle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2006-12       Impact factor: 1.827

2.  The microenvironment in the Hirschsprung's disease gut supports myenteric plexus growth.

Authors:  Cornelia Irene Hagl; Ulrich Rauch; Markus Klotz; Sabine Heumüller; David Grundmann; Sabrina Ehnert; Ulrike Subotic; Stefan Holland-Cunz; Karl-Herbert Schäfer
Journal:  Int J Colorectal Dis       Date:  2012-06       Impact factor: 2.571

3.  Smooth muscle proteins from Hirschsprung's disease facilitates stem cell differentiation.

Authors:  Cornelia Irene Hagl; Sabine Heumüller; Markus Klotz; Ulrike Subotic; Lucas Wessel; Karl-Herbert Schäfer
Journal:  Pediatr Surg Int       Date:  2012-02       Impact factor: 1.827

4.  Enteric Glial Dysfunction Evoked by Apolipoprotein E Deficiency Contributes to Delayed Gastric Emptying.

Authors:  Seiichiro Fukuhara; Tatsuhiro Masaoka; Soraya Nishimura; Masaya Nakamura; Juntaro Matsuzaki; Hitoshi Tsugawa; Sawako Miyoshi; Hideki Mori; Satoshi Kawase; Shinsuke Shibata; Hideyuki Okano; Takanori Kanai; Hidekazu Suzuki
Journal:  Dig Dis Sci       Date:  2017-11-02       Impact factor: 3.199

5.  Gdnf haploinsufficiency causes Hirschsprung-like intestinal obstruction and early-onset lethality in mice.

Authors:  Liya Shen; José G Pichel; Thomas Mayeli; Hannu Sariola; Bai Lu; Heiner Westphal
Journal:  Am J Hum Genet       Date:  2002-01-03       Impact factor: 11.025

6.  Effects of NRG1 Polymorphisms on Hirschsprung's Disease Susceptibility: A Meta-analysis.

Authors:  Meng Jiang; Changli Li; Guoqing Cao; Dehua Yang; Xi Zhang; Li Yang; Shuai Li; Shao-Tao Tang
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.